We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bexarotene With Narrow-Band UVB for Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00151008
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : August 7, 2008
Sponsor:
Collaborator:
Ligand Pharmaceuticals
Information provided by:
Rutgers, The State University of New Jersey

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : August 2005